Ophthalmology · Pearland, TX
NPI
1154777886
Since 2016
Specialty
Ophthalmology
Code 207W00000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
10907 Memorial Hermann Dr Ste 150
Pearland, TX, 77584
Phone (281) 582-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$784K
4,569 services
Medicare patients, 2024
194
Average age 79
Drug cost, 2024
$2.3M
1,769 prescriptions
Company payments, 2025
$2,979
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bilal Shaukat was code J0178 (injection, aflibercept, 1 mg), 795 times for 65 patients. In total Bilal Shaukat billed 4,569 services in 27 codes, and Medicare paid $784K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0178 Injection, aflibercept, 1 mg | Office | 795 | 65 | $654.06 | $520K |
| 92134 Computerized Ophthalmic Imaging | Office | 624 | 175 | $29.57 | $18K |
| 67028 Intravitreal Injection | Office | 501 | 78 | $88.48 | $44K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 352 | 13 | $263.48 | $93K |
| 92014 Ophthalmological E&M | Office | 312 | 180 | $89.46 | $28K |
| 92012 Ophthalmological E&M | Office | 85 | 54 | $63.41 | $5,390 |
| J7999 Compounded drug, not otherwise classified | Office | 46 | 16 | $53.89 | $2,479 |
| 76512 Ultrasound - Nonspecific | Office | 18 | 12 | $37.36 | $673 |
By year: 2022 $76K for 576 services; 2023 $294K for 1,980 services; 2024 $784K for 4,569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bilal Shaukat prescribed most often to Medicare patients was Eylea (Aflibercept), with 635 prescriptions and refills. In total Bilal Shaukat wrote 1,769 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 635 | 649 | 133 | $1.4M |
| Prednisolone Acetate Generic | 262 | 412 | 162 | $11K |
| Eylea Hd Aflibercept | 138 | 143 | 27 | $444K |
| Atropine Sulfate Generic | 100 | 120 | 81 | $3,272 |
| Ciprofloxacin Hcl Generic | 94 | 104 | 82 | $1,500 |
| Latanoprost Generic | 79 | 162 | 34 | $836 |
| Vabysmo Faricimab-Svoa | 62 | 65 | 19 | $156K |
| Ketorolac Tromethamine Generic | 59 | 97 | 45 | $1,910 |
| Syfovre Pegcetacoplan/Pf | 50 | 51 | 11 | $120K |
| Timolol Maleate Generic | 43 | 106 | 20 | $442 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 34 | 67 | 17 | $635 |
| Ozurdex Dexamethasone | 31 | 77 | 17 | $44K |
| Combigan Brimonidine Tartrate/Timolol | 28 | 43 | Under 11 | $7,821 |
| Brimonidine Tartrate Generic | 25 | 57 | 12 | $532 |
| Lumigan Bimatoprost | 14 | 33 | Under 11 | $6,945 |
Brand drugs: 1,366 claims; generic drugs: 403 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bilal Shaukat $2,979 ($829 in general payments such as food, travel and fees and $2,150 for research) from 11 companies. The largest payer was Notal Vision, Inc. with $1,200.
| Company | Payments | Amount |
|---|---|---|
| Notal Vision, Inc. | 30 | $1,200 |
| Regeneron Pharmaceuticals, Inc. REGN | 9 | $1,116 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $147 |
| Harrow Eye, LLC | 4 | $122 |
| Genentech USA, Inc. ROG.SW | 4 | $97.27 |
| Amgen Inc. AMGN | 4 | $70.14 |
| Alcon Vision LLC ALC | 1 | $58.73 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $52.36 |
| Abbvie Inc. ABBV | 2 | $44.87 |
| Sandoz Inc. SDZ.SW | 2 | $41.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.